Gilead, Janssen Settle HIV Treatment Suits With Lupin, Apotex <https://www.law360.com/delaware/articles/2300071?nl_pk=9f0ef0c6-df48-47ce-8c94-4f68ac959c6f&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2025-02-20&read_main=1&nlsidx=0&nlaidx=1> By Andrea Keckley Gilead Sciences Inc. and Johnson & Johnson's Janssen unit settled their patent suits against Lupin and Apotex over generic versions of HIV treatments, according to filings in Delaware federal court on Wednesday. Read full article » <https://www.law360.com/delaware/articles/2300071?nl_pk=9f0ef0c6-df48-47ce-8c94-4f68ac959c6f&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2025-02-20&read_more=1&nlsidx=0&nlaidx=1> | Save to favorites » <https://www.law360.com/delaware/articles/2300071?nl_pk=9f0ef0c6-df48-47ce-8c94-4f68ac959c6f&utm_source=newsletter&utm_medium=email&utm_campaign=delaware&utm_content=2025-02-20&read_later=1&nlsidx=0&nlaidx=1>